<p>Left) Two-way sensitivity analysis of the effects of changes in IGRA sensitivity and specificity parameters within pre-specified ranges on DALYs averted, demostrating the most effective diagnostic strategy, irrespective of cost. Right) Two-way sensitivity analysis of the effects of changes in IGRA and Xpert MTB/Rif prices within pre-specified ranges on the cost of each diagnostic approach, demostrating the least costly diagnostic strategy, irrespective of effectiveness.</p
<p>One-way sensitivity analyses of cost-effectiveness for different anemia treatment targets.</p
<p>(a) OS in univariate analysis, (b) OS in multivariate analysis, (c) DFS in univariate analysis, a...
<p>One-way sensitivity analysis of selected variables on the cost advantage of the tissue engineerin...
<p>Top) Tornado diagram examining model parameters with the largest impact on the cost of the IGRA t...
<p>Sensitivity analysis: variation in cost/LYG through screening by varied testing and drug costs, p...
One- and two-way sensitivity analyses for the estimated annual direct cost of HF in each phenotype a...
<p>The sensitivity analysis recalculates the net expected cost of each strategy (Scr vs. uNGAL+Scr),...
<p>Sensitivity analyses on the incremental cost per DALY averted (2011 US dollars) over a 10-y analy...
Sensitivity analysis based on IgM for assessing the effect of each primary study on the total estima...
Sensitivity analysis based on IgG for assessing the effect of each primary study on the total estima...
<p>All costs in US dollars. Incremental cost-effectiveness thresholds obtained in one-way sensitivit...
Two-way sensitivity analysis simultaneously varying the utility weight of mild age-related macular d...
<p>Sensitivity Analyses exploring influence of cost outliers and individual trials, NHS and Societal...
<p><sup></sup> The effect of assumptions on the ICER of Xpert-for-all compared to triage pathway wit...
<p>One-way sensitivity analyses of the incremental cost-effectiveness of PrEP.</p
<p>One-way sensitivity analyses of cost-effectiveness for different anemia treatment targets.</p
<p>(a) OS in univariate analysis, (b) OS in multivariate analysis, (c) DFS in univariate analysis, a...
<p>One-way sensitivity analysis of selected variables on the cost advantage of the tissue engineerin...
<p>Top) Tornado diagram examining model parameters with the largest impact on the cost of the IGRA t...
<p>Sensitivity analysis: variation in cost/LYG through screening by varied testing and drug costs, p...
One- and two-way sensitivity analyses for the estimated annual direct cost of HF in each phenotype a...
<p>The sensitivity analysis recalculates the net expected cost of each strategy (Scr vs. uNGAL+Scr),...
<p>Sensitivity analyses on the incremental cost per DALY averted (2011 US dollars) over a 10-y analy...
Sensitivity analysis based on IgM for assessing the effect of each primary study on the total estima...
Sensitivity analysis based on IgG for assessing the effect of each primary study on the total estima...
<p>All costs in US dollars. Incremental cost-effectiveness thresholds obtained in one-way sensitivit...
Two-way sensitivity analysis simultaneously varying the utility weight of mild age-related macular d...
<p>Sensitivity Analyses exploring influence of cost outliers and individual trials, NHS and Societal...
<p><sup></sup> The effect of assumptions on the ICER of Xpert-for-all compared to triage pathway wit...
<p>One-way sensitivity analyses of the incremental cost-effectiveness of PrEP.</p
<p>One-way sensitivity analyses of cost-effectiveness for different anemia treatment targets.</p
<p>(a) OS in univariate analysis, (b) OS in multivariate analysis, (c) DFS in univariate analysis, a...
<p>One-way sensitivity analysis of selected variables on the cost advantage of the tissue engineerin...